Darne J F, Polacarz S V, Sheridan E, Anderson D, Ginsberg R, Sharp F
Clinical Sciences Centre, Northern General Hospital, Sheffield.
J Clin Pathol. 1990 Aug;43(8):657-60. doi: 10.1136/jcp.43.8.657.
Silver binding nucleolar regions (AgNORs) were evaluated in normal endocervix, adenocarcinoma, and its potential precursor, adenocarcinoma in situ (AIS), in an attempt to increase an understanding of the natural history of cervical adenocarcinoma and to identify a marker for abnormal endocervical (atypical glandular) cells which could aid diagnosis and follow up of endocervical lesions. For every 50 cells the mean AgNOR counts were as follows: normal endocervical cells (n = 15) 79.8 (95% Cl 68-91); AIS (n = 20) 200.7 (95% Cl 182-219); and invasive adenocarcinoma (n = 30) 299 (271-328). There was no overlap between the groups of normal endocervical cells and invasive adenocarcinoma, but there was significant overlap between cases of invasive adenocarcinoma and carcinoma in situ. In six out of 17 cases with AIS, NOR count in adjacent morphologically normal glandular cells ("internal" controls) was increased when compared with the "external" (normal endocervical) control group. This suggests the presence of wider field changes not previously identified using routine histological methods. The findings suggest that AIS is a potential premalignant precursor of invasive adenocarcinoma, but that assessment of NORs is of no practical use in discriminating between the histological types of cervical carcinoma.
对正常宫颈、腺癌及其潜在前驱病变原位腺癌(AIS)进行了银结合核仁区(AgNORs)评估,旨在增进对宫颈腺癌自然史的了解,并确定一种有助于宫颈管异常(非典型腺性)细胞诊断及宫颈管病变随访的标志物。每50个细胞的平均AgNOR计数如下:正常宫颈管细胞(n = 15)为79.8(95%可信区间68 - 91);原位腺癌(n = 20)为200.7(95%可信区间182 - 219);浸润性腺癌(n = 30)为299(271 - 328)。正常宫颈管细胞组与浸润性腺癌组之间无重叠,但浸润性腺癌病例与原位癌之间存在显著重叠。在17例原位腺癌病例中,有6例的相邻形态学正常腺性细胞(“内部”对照)的NOR计数与“外部”(正常宫颈管)对照组相比有所增加。这表明存在常规组织学方法以前未发现的更广泛区域变化。研究结果提示,原位腺癌是浸润性腺癌潜在的癌前前驱病变,但NOR评估在鉴别宫颈癌组织学类型方面并无实际用途。